Rollins Emily, director at Dolby Laboratories, sells $60,080 in stock By Investing.com
Emily Rollins, a director at Dolby Laboratories, Inc. (NASDAQ:DLB), sold 1,000 shares of Class A Common Stock for $60,080 on April 1, 2026. Following the sale, Rollins directly owns 12,541 shares. This transaction occurred shortly after Dolby Laboratories reported strong first-quarter 2026 financial results, with EPS and revenue exceeding expectations.
Rollins Emily, director at Dolby Laboratories, sells $60,080 in stock
Emily Rollins, a director at Dolby Laboratories (NASDAQ:DLB), sold 1,000 shares of Class A Common Stock for a total of $60,080 on April 1, 2026. Following this transaction, Rollins directly owns 12,541 shares. This sale comes after Dolby Laboratories reported strong financial results for Q1 2026, with EPS and revenue surpassing expectations.
Director at Dolby Laboratories (DLB) sells 1,000 shares, holds 12,541
Emily Rollins, a director at Dolby Laboratories (DLB), reported an open-market sale of 1,000 shares of Class A common stock at $60.08 per share on April 1, 2026. Following this transaction, she directly holds 12,541 shares, which include 3,908 shares underlying restricted stock units that are subject to forfeiture until they vest. The transaction, filed as a Form 4, indicates a net sale of 1,000 shares valued at $60,080.
Rollins Emily, director at Dolby Laboratories, sells $60,080 in stock
Emily Rollins, a director at Dolby Laboratories, Inc. (NASDAQ:DLB), sold 1,000 shares of Class A Common Stock for $60.08 per share, totaling $60,080. Following the transaction, Rollins retains direct ownership of 12,541 shares. This sale comes as Dolby Laboratories recently reported strong first-quarter 2026 financial results, with EPS and revenue surpassing expectations.
Free cash flow per share of Dolby Laboratories, Inc. Class A – TRADEGATE:FUO
This article displays information regarding the free cash flow per share of Dolby Laboratories, Inc. Class A (FUO) on the Tradegate Exchange. It highlights financial data and market details for the company. The page appears to be a financial data presentation typical of a trading platform like TradingView.
EBITDA per share of Dolby Laboratories, Inc. Class A – MUN:FUO
This page provides financial data, specifically EBITDA per share, for Dolby Laboratories, Inc. Class A (MUN:FUO) on the Munich Stock Exchange. The content is primarily a data display with navigation and disclaimer information, indicating the market is closed for this listing.
Vanguard disaggregates holdings after realignment (DLB) — reports 0 shares
The Vanguard Group has filed an amended Schedule 13G/A, reporting zero beneficial ownership of Dolby Laboratories Inc. common stock. This change follows an internal realignment on January 12, 2026, where certain Vanguard subsidiaries and business divisions began reporting beneficial ownership separately, in accordance with SEC Release No. 34-39538. Previously aggregated holdings are now disaggregated, meaning The Vanguard Group itself no longer reports beneficial ownership for these entities.
Dolby Named to Fast Company's Annual List of the World's Most Innovative Companies List for Fourth Time
Dolby Laboratories has been named to Fast Company's World's Most Innovative Companies list for the fourth time, recognized in the Consumer Electronics category for Dolby Vision 2. This breakthrough technology enhances TV picture quality by addressing common viewing challenges and providing a more cinematic experience. Major TV brands like Hisense, TCL, and TP Vision, along with content providers Peacock and CANAL+, are adopting Dolby Vision 2, cementing Dolby's leadership in immersive entertainment innovation.
DLB SEC Filings - Dolby Laboratories Inc 10-K, 10-Q, 8-K Forms
This page provides comprehensive access to Dolby Laboratories (DLB) SEC filings, including 10-K, 10-Q, 8-K, and insider trading forms. It details the company's licensing-focused business model, financial performance, governance practices, and recent insider transactions. The platform also offers AI-powered summaries to help investors understand complex financial documents.
DLB SEC Filings - Dolby Laboratories Inc 10-K, 10-Q, 8-K Forms
This page on Stock Titan provides comprehensive access to Dolby Laboratories Inc. (DLB) SEC filings, including annual reports (10-K), quarterly updates (10-Q), material events (8-K), and insider trading forms. It details Dolby's licensing-focused business model, its various technologies, and how filings disclose financial results, dividends, executive compensation, and corporate governance. The platform also offers AI-powered summaries to help investors understand complex financial and governance information.
[Form 4] Dolby Laboratories, Inc. Insider Trading Activity
A recent Dolby Laboratories, Inc. Form 4 filing details insider trading activity related to Dagmar Dolby. The filing indicates the transfer of 1,000,000 shares of Class B Common Stock to a grantor retained annuity trust for tax and estate planning, and the conversion and gifting of 10,000 Class B shares to Class A shares to a charitable organization. Dagmar Dolby disclaims beneficial ownership beyond her pecuniary interest in these indirect holdings.
Dolby (NYSE: DLB) VP sells 2,667 shares after option exercise
Dolby Laboratories VP, CAO, and Corporate Controller Ryan Nicholson exercised employee stock options for 2,667 Class A common shares at $45.50 per share and subsequently sold all 2,667 shares on the open market at a weighted average price of $66.3752. These transactions, which occurred on February 13, 2026, resulted in a negative filing sentiment, though Nicholson still directly owns 36,956 Class A shares, including unvested restricted stock units.
Shriram Revankar, Dolby Labs SVP, sells $198k in stock By Investing.com
Shriram Revankar, Senior Vice President at Dolby Laboratories Inc. (NASDAQ:DLB), sold 3,000 shares of Class A Common Stock for a total of $198,420. This transaction leaves him with 83,218 shares, including restricted stock units. The sale follows Dolby Laboratories reporting strong financial results for the first quarter of 2026, with both EPS and revenue surpassing expectations.
Shriram Revankar, Dolby Labs SVP, sells $198k in stock By Investing.com
Shriram Revankar, SVP at Dolby Laboratories, Inc., sold 3,000 shares of Class A Common Stock for $198,420, leaving him with 83,218 shares. This sale follows strong Q1 2026 financial results for Dolby, which saw EPS and revenue surpass analyst expectations. The article highlights Dolby's robust performance, with both earnings and revenue beating projections.
Shriram Revankar, Dolby Labs SVP, sells $198k in stock By Investing.com
Shriram Revankar, SVP at Dolby Laboratories (NASDAQ:DLB), sold 3,000 shares of Class A Common Stock for $198,420 on February 17, 2026. Following the sale, Revankar now holds 83,218 shares. This transaction comes shortly after Dolby Laboratories reported strong Q1 2026 financial results, exceeding EPS and revenue forecasts.
Dolby Labs VP Nicholson sells $177k in shares By Investing.com
Ryan Nicholson, VP, CAO and Corp. Controller at Dolby Laboratories (NASDAQ:DLB), sold 2,667 shares of Class A Common Stock for over $177,000 and also exercised options for 2,667 shares. Despite a recent stock drop, Dolby shows strong financial health with an impressive gross profit margin and a 12-year dividend increase streak, alongside beating recent Q1 2026 EPS and revenue expectations.
Dolby Labs VP Nicholson sells $177k in shares
Ryan Nicholson, VP at Dolby Laboratories (NASDAQ:DLB), sold 2,667 shares for $177,022 and exercised options for the same number of shares. This occurred as Dolby's stock is down 22% over the past year, trading near its 52-week low. Despite the stock performance, the company reports strong financial health with an 87.86% gross profit margin, a 2.26% dividend yield, and recently exceeded Q1 2026 earnings and revenue expectations.
Shriram Revankar, Dolby Labs SVP, sells $198k in stock By Investing.com
Shriram Revankar, SVP at Dolby Laboratories Inc. (NASDAQ:DLB), sold 3,000 shares of Class A Common Stock for $198,420 on February 17, 2026. Following the sale, Revankar now holds 83,218 shares, including restricted stock units. This transaction occurred shortly after Dolby Laboratories reported strong first-quarter 2026 financial results, exceeding both EPS and revenue expectations.
Dolby Laboratories (DLB) investors approve directors, executive pay and KPMG at 2026 meeting
Dolby Laboratories (DLB) shareholders held their 2026 Annual Meeting on February 3, 2026, electing all eight director nominees, including Kevin Yeaman and David Dolby. They also approved the compensation for named executive officers on an advisory basis and ratified KPMG LLP as the independent registered public accounting firm for the fiscal year ending September 25, 2026. The decisions reflect broad shareholder support for the current board, executive pay, and auditor.
Source-Connect 4 Becomes First metadata-connected Dolby® Atmos remote review & approval tool
Source Elements has announced that Source-Connect 4 is the first remote collaboration solution to achieve Dolby Atmos certification with metadata connection. This integration allows mixers, directors, and stakeholders to remotely participate in Dolby Atmos playback and mixing sessions with 128 audio streaming channels, including full metadata. The technology streams the complete Dolby Atmos project, ensuring high-quality, synchronized collaboration across different setups and locations without the need for re-renders or channel limitations.
Mahindra launches XUV 7XO as India's first vehicle with Dolby Vision and Dolby Atmos, redefining the future of in-car...
Mahindra and Dolby Laboratories have launched the all-new Mahindra XUV 7XO, making it India's first vehicle to offer both Dolby Vision and Dolby Atmos for in-car entertainment. This innovation aims to transform the in-car experience with immersive visuals and spatial sound. Consumers can enjoy content from platforms like Gaana and Sony LIV directly integrated into the vehicle's entertainment system.
Dolby Labs Auto And Vision 2 Gains Raise Valuation Questions For Investors
Dolby Laboratories is expanding its presence in automotive audio, partnering with over 35 OEMs, and received positive feedback for Dolby Vision 2 at CES 2026. These developments mark a shift beyond traditional cinema and home entertainment, with the company's valuation suggesting it trades below fair value despite these gains. Investors should monitor automotive royalty traction and Dolby Vision 2 adoption, while also considering concerns like recent insider selling.
Dolby Laboratories (DLB) Margin Compression Tests Bullish Earnings Growth Narratives
Dolby Laboratories (DLB) reported Q1 2026 revenue of US$346.7 million and basic EPS of US$0.56, initiating the fiscal year. Despite projected annual earnings growth of about 11.5%, the company is experiencing margin compression, with net margins falling from 20.5% to 18.9% year-over-year and a five-year earnings decline of 3.1% annually. This mixed performance challenges bullish narratives and prompts investors to scrutinize the consistency of future growth, especially given a P/E of 23.5x and a DCF fair value significantly higher than the current stock price.
Dolby Laboratories Reports First Quarter 2026 Financial Results
Dolby Laboratories announced its financial results for the first quarter of fiscal 2026, reporting total revenue of $347 million and GAAP net income of $53 million. The company highlighted strong momentum with Dolby Atmos and Dolby Vision, expansion into new markets, and significant partnerships with auto OEMs and streaming services. Dolby also provided financial estimates for the second quarter and full year of fiscal 2026, including expected revenue and earnings per share.
Dolby Laboratories (NYSE:DLB) within Russell 1000 Shaping Audio Standards
Dolby Laboratories, Inc. (NYSE:DLB), a component of the Russell 1000 Index, specializes in developing and licensing advanced audio and imaging technologies. The company's innovations are utilized across various platforms including cinema, streaming, gaming, and consumer devices, setting high standards in entertainment experiences. This article highlights Dolby's role in shaping audio standards and its inclusion in a significant market index.
Dolby Laboratories Reports First Quarter 2026 Financial Results
Dolby Laboratories announced its first-quarter fiscal 2026 financial results, with total revenue of $347 million and GAAP net income of $53 million. The company highlighted strong momentum for Dolby Atmos and Dolby Vision, expanding its market with new partnerships in automotive, streaming, and consumer electronics. Dolby also provided a positive financial outlook for the second quarter and full fiscal year 2026, projecting increased revenue and earnings per share.
Earnings Flash (DLB) Dolby Laboratories, Inc. Reports Q1 Revenue $346.7M, vs. FactSet Est of $332.3M
Dolby Laboratories, Inc. (DLB) reported its Q1 revenue of $346.7 million, surpassing FactSet's estimate of $332.3 million. This announcement was part of their earnings report for the first quarter ended December 26, 2025. The company also provided earnings guidance for the second quarter and the full fiscal year 2026, while maintaining its cash dividend.
Dolby Laboratories Reports First Quarter 2026 Financial Results
Dolby Laboratories announced its financial results for the first quarter of fiscal 2026, reporting total revenue of $347 million and GAAP net income of $53 million. The company highlighted strong momentum with Dolby Atmos and Dolby Vision, with expansions into automotive OEMs and streaming services like Peacock. Dolby also provided financial estimates for the second quarter and full fiscal year 2026, anticipating continued growth in revenue and earnings per share.
Bengaluru Dolby Cinema Opening Raises Questions On Dolby Valuation
Dolby Laboratories recently opened its first Dolby Cinema in Bengaluru, India, expanding its premium footprint in a key entertainment market. This development comes as Dolby's stock has seen significant declines over the past one and five years, prompting investors to consider how these new partnerships impact the company's valuation. While Simply Wall St flags the stock as undervalued and below analyst targets, insider selling over the last three months presents a potential risk.
Dolby Cinema Arrives in Bengaluru: Dolby Laboratories and AMB Cinemas Bring a Truly Unique and Transformative Experience to the Tech Capital
Dolby Laboratories and AMB Cinemas have launched Bengaluru's first Dolby Cinema at AMB Cinemas, Kapali, marking India's second Dolby Cinema location. This new 588-seater auditorium aims to transform the movie-watching experience in Bengaluru by offering world-class visual and audio excellence through Dolby Vision and Dolby Atmos technologies. The launch signifies a major step in expanding Dolby Cinema's presence in India and allows audiences to experience films exactly as filmmakers intended.
Dolby Laboratories Announces Conference Call and Webcast for Q1 Fiscal 2026 Financial Results
Dolby Laboratories, Inc. (NYSE: DLB) will release its Q1 fiscal year 2026 financial results on Thursday, January 29, 2026, after market close. A conference call and webcast will follow at 2:00 p.m. PT to discuss the results, with replay options available. The company highlights its leadership in immersive entertainment experiences and lists contact information for investor and media inquiries.
Dolby Sets the New Standard for Premium Entertainment at CES 2026
Dolby Laboratories showcased its latest innovations at CES 2026, aiming to redefine entertainment experiences in streaming, home entertainment, and automotive sectors. Key announcements include a partnership with Peacock to integrate Dolby Vision and Dolby Atmos, the expansion of Dolby Vision 2 with major TV manufacturers, and increased adoption of Dolby Atmos in over 35 global automotive brands. These advancements highlight Dolby's commitment to delivering more immersive and accessible premium quality entertainment.
Do You Believe in the Growth Potential of Dolby Laboratories (DLB)?
Aristotle Capital Boston’s Small Cap Equity Fund highlighted Dolby Laboratories, Inc. (NYSE: DLB) in its Q3 2025 investor letter, citing expected higher margins from deeper market penetration of its Atmos and Vision technologies and its capital-efficient operating model. Despite a recent stock decline, the fund sees potential in Dolby’s audio-video technology licensing business. However, the article also notes that Dolby is not among the top 30 hedge fund holdings and suggests other AI stocks might offer greater upside with less risk.
Do You Believe in the Growth Potential of Dolby Laboratories (DLB)?
Aristotle Capital Boston, LLC's "Small Cap Equity Fund" highlighted Dolby Laboratories, Inc. (NYSE: DLB) in its Q3 2025 investor letter, noting its potential for higher margins due to deeper market penetration of its Atmos and Vision technologies. Despite the company's capital-efficient operating model generating attractive cash flow, the fund suggests that certain AI stocks offer greater promise for higher returns in a shorter timeframe. While 23 hedge funds held DLB in Q3 2025, the article emphasizes exploring AI stocks with substantial upside potential instead.
Have Dolby Laboratories Insiders Been Selling Stock?
Recent insider transactions at Dolby Laboratories (NYSE:DLB) show selling activity, with the Senior VP of Entertainment selling shares worth US$500k and the Senior VP & Chief Marketing Officer making a larger sale of US$907k previously. Despite these sales, the larger transaction occurred at a price higher than the current stock value. Insider ownership stands at 0.5% of shares, suggesting some alignment with shareholders but warranting caution given the sales history.
The Movie Experience SLO Becomes First U.S. Exhibitor to Adopt Dolby Vision+Atmos Theatrical Solution
The Movie Experience SLO: Downtown Centre Cinemas has become the first U.S. theatrical exhibitor to adopt the Dolby Vision+Atmos solution, integrating it into a new black box auditorium with a floating screen in San Luis Obispo, CA. This partnership between Dolby Laboratories and The Movie Experience SLO aims to provide an industry-leading premium sight and sound experience for moviegoers. The technology promises to deliver a more vivid, captivating, and unforgettable way to enjoy films, attracting audiences back to theaters.
Form DEF 14A Dolby Laboratories, Inc. For: Feb 03
This DEF 14A filing by Dolby Laboratories, Inc. is a definitive proxy statement for their Annual Meeting of Stockholders to be held virtually on February 3, 2026. The document details proposals including the election of eight directors, an advisory vote on Named Executive Officer compensation, and the ratification of KPMG LLP as their independent registered public accounting firm. It provides extensive information on executive and director compensation, corporate governance practices, related person transactions, and financial highlights for fiscal year 2025.
TATA MOTORS PASSENGER VEHICLES LTD. AND DOLBY LABORATORIES BRING DOLBY ATMOS TO THE ALL – NEW TATA SIERRA
Tata Motors Passenger Vehicles Ltd. and Dolby Laboratories announced their collaboration to bring Dolby Atmos immersive sound to the All-New Tata Sierra. This integration will provide a premium in-car entertainment experience with a 12-speaker audio system, allowing users to enjoy music and audiobooks with enhanced clarity and sound separation. The partnership aims to transform in-car entertainment into an emotionally engaging experience for drivers and passengers in India.
Dolby Labs CEO Yeaman sells $2.45m in shares By Investing.com
Kevin J. Yeaman, President and CEO of Dolby Laboratories, sold 36,699 shares of Class A Common Stock for over $2.45 million on November 24, 2025, with the stock trading near its 52-week low. He also exercised options to acquire additional shares and gifted 16,348 shares to a Donor-Advised Fund for charitable purposes. These transactions come amidst Dolby reporting better-than-expected fourth-quarter earnings, though a lowered price target was issued by Rosenblatt due to macroeconomic challenges.
Dolby Labs CEO Yeaman sells $2.45m in shares By Investing.com
Kevin J. Yeaman, CEO of Dolby Laboratories Inc. (NASDAQ:DLB), sold 36,699 shares for $2.45 million on November 24, 2025, with shares trading near their 52-week low. He also exercised options to acquire additional shares and gifted 16,348 shares to a Donor-Advised Fund for charitable purposes. Despite recent transactions, Yeaman still holds 127,735 shares underlying restricted stock units.
Dolby Laboratories SVP Revankar sells $196k in shares
Shriram Revankar, SVP at Dolby Laboratories (NYSE:DLB), sold 3,000 shares of Class A Common Stock for $196,650 on November 21, 2025, according to an SEC filing. This transaction occurred while Dolby shares were near their 52-week low, though the company maintains strong financials with impressive gross profit margins and a history of dividend increases. Dolby recently exceeded Q4 earnings and revenue expectations, but a lowered price target from Rosenblatt due to macroeconomic challenges reflects ongoing market concerns.
Dolby Laboratories SVP Revankar sells $196k in shares By Investing.com
Shriram Revankar, SVP at Dolby Laboratories, sold 3,000 shares of Class A Common Stock for $196,650 on November 21, 2025. This transaction occurred as Dolby shares traded near their 52-week low, though InvestingPro data suggests the company is undervalued. Dolby Laboratories maintains strong financials with impressive gross profit margins and a consistent dividend record.
Dolby Laboratories SVP Revankar sells $196k in shares By Investing.com
Shriram Revankar, SVP at Dolby Laboratories, sold 3,000 shares of Class A Common Stock for $196,650 on November 21, 2025. This transaction occurred while Dolby shares were trading near their 52-week low, though InvestingPro data suggests the company is undervalued. Dolby Laboratories maintains strong financial health with impressive gross profit margins, more cash than debt, and a history of consistent dividend increases.
BAY AREA HOST COMMITTEE AND DOLBY PARTNER TO DELIVER IMMERSIVE FAN EXPERIENCES
The Bay Area Host Committee (BAHC) and Dolby Laboratories announced a multi-faceted partnership to deliver immersive fan experiences during Super Bowl LX and its surrounding festivities in February 2026. Dolby will showcase its technologies like Dolby Vision, Dolby Atmos, and Dolby OptiView to enhance live sports and real-time streaming, aiming to redefine how fans engage with major sporting events. This collaboration also includes community programs and an Innovation Summit, highlighting the intersection of technology, creativity, and community in the Bay Area.
Dolby Laboratories Reports Fourth Quarter and Fiscal Year 2025 Financial Results
Dolby Laboratories announced strong fourth quarter and fiscal year 2025 financial results, with total revenue reaching $307 million for Q4 and $1.35 billion for the full fiscal year. The company reported significant growth in Dolby Atmos, Dolby Vision, and imaging patents, expanding its market reach with new initiatives like Dolby OptiView. Dolby also provided an optimistic financial outlook for fiscal year 2026, anticipating continued revenue growth and operating margin improvements.
Dolby Laboratories Reports Fourth Quarter and Fiscal Year 2025 Financial Results
Dolby Laboratories announced strong financial results for the fourth quarter and full fiscal year 2025, with total revenue reaching $307 million for Q4 and $1.35 billion for the full year. The company highlighted growth in Dolby Atmos, Dolby Vision, and new imaging patents, along with strategic partnerships and product launches across various platforms and industries. Dolby also provided a positive financial outlook for the first quarter and full fiscal year 2026, projecting continued revenue growth and operating margins.
Dolby Laboratories, Inc. Q4 2025 Earnings Preview
This article is a preview of Dolby Laboratories, Inc.'s Q4 2025 earnings. It indicates that the content associated with this preview is currently missing or unavailable from the provided source.
Dolby Laboratories Inc-Class A (NYSE:DLB) Posts Mixed Q4 2025 Results with Strong Earnings Beat
Dolby Laboratories Inc-Class A (NYSE:DLB) reported mixed financial results for Q4 2025, significantly beating analyst expectations on non-GAAP EPS with $0.99 against an estimate of $0.707, while revenue slightly missed at $307.02 million against a $307.74 million consensus. This led to a slight decline in after-market trading. Analysts project $1.42 billion in sales for fiscal year 2026 and $370.63 million revenue with $1.15 EPS for Q1 2026.
The Returns At Dolby Laboratories (NYSE:DLB) Aren't Growing
Dolby Laboratories (NYSE:DLB) demonstrates an ROCE of 10%, which is satisfactory and above the Software industry average. However, the company's ROCE and capital employed have remained flat over the past five years, indicating a mature business rather than a growth-phase company. Consequently, the stock has underperformed, suggesting it may not be a multi-bagger investment unless future investment significantly increases.
TD Asset Management Inc Has $1.24 Million Stock Position in Dolby Laboratories $DLB
TD Asset Management Inc significantly increased its stake in Dolby Laboratories, holding 16,700 shares valued at $1.24 million. Concurrently, several insiders, including CEO Kevin J. Yeaman, sold substantial amounts of Dolby Laboratories stock. The company reported a 9.2% year-over-year revenue increase and provided FY 2025 EPS guidance, while analysts maintain a "Moderate Buy" consensus rating for DLB.
